Grifols has started the year on a good note, driven by a sustained recovery in plasma supply – now back to pre-pandemic levels. Moreover, supply should improve further as the pandemic recedes, and its recently-added plasma centres start to contribute to their full potential. While its exorbitantly high leverage is a key headwind, the group is confident of successful deleveraging, driven by improving operational performance – the signs of which are already visible. Hence, our positive recommendat ....
06 May 2022
Encouraging start to the year
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Encouraging start to the year
- Published:
06 May 2022 -
Author:
Amandeep Goyal -
Pages:
3
Grifols has started the year on a good note, driven by a sustained recovery in plasma supply – now back to pre-pandemic levels. Moreover, supply should improve further as the pandemic recedes, and its recently-added plasma centres start to contribute to their full potential. While its exorbitantly high leverage is a key headwind, the group is confident of successful deleveraging, driven by improving operational performance – the signs of which are already visible. Hence, our positive recommendat ....